Risuteganib for the treatment of DME

Article

Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research  in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.